Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peptide-based Immunization for Colon- and Pancreas-carcinoma (PICOP-GLOBAL): An International, Multicenter Protocol

NCT03871790 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT03871790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03871790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peptide-based Immunization for Colon- and Pancreas-carcinoma (PICOP-GLOBAL): An International, Multicenter Protocol
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Completed
Start date
April 1, 2019
Completion date
August 31, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer, colon adenocarcinoma, colon cancer, colon neoplasm, pancreas cancer, pancreatic adenocarcinoma, pancreatic cancer, pancreatic neoplasms, rectal adenocarcinoma, rectal cancer, rectal neoplasms, rectal tumors